GENFIT and LabCorp partner to develop test for liver disease

LabCorp will develop a blood-based molecular diagnostic test, using GENFIT’s NIS4 technology to help identify patients with at-risk non-alcoholic steatohepatitis. Credit: Michal Jarmoluk / Pixabay.



  • GENFIT